A phase II trial of docetaxel (Taxotere) in hormone-refractory prostate cancer: correlation of antitumor effect to phosphorylation of Bcl-2.
Year: 1999
Type: article
Study design: Clinical Trial
Source: PubMed
Authors: D Friedland, J Cohen, R Miller, M Voloshin, R Gluckman, B Lembersky, B Zidar, M Keating, N Reilly, B Dimitt
Institution: Allegheny Health Network
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W95159028